NEW CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR COMPOUND

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240116900A1
SERIAL NO

18250466

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are crystalline forms of a KRAS G12C inhibitor compound and to processes for their preparation. Furthermore, provided is pharmaceutical composition comprising said crystalline forms, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition can be used as a medicament, in particular for the treatment of cancer, and KRAS G12C-mutant cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGBASEL SUI

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
COTESTA, Simona Basel, CH 25 71
GE, Heng Changshu, Jiangsu, CN 4 16
GERSPACHER, Marc Basel, CH 25 63
LEBLANC, Catherine Basel, CH 54 245
LIU, Bo Shanghai, CN 672 3701
LORTHIOIS, Edwige Liliane Jeanne Basel, CH 19 281
LOZAC'H, Marie-Anne Basel, CH 1 0
MACHAUER, Rainer Basel, CH 39 248
MAH, Robert Basel, CH 82 419
MEISTER, Tanja Basel, CH 2 3
MURA, Christophe Basel, CH 5 0
RIGOLLIER, Pascal Basel, CH 32 223
SCHNEIDER, Nadine Basel, CH 7 8
STRANG, Ross Basel, CH 4 19
STUTZ, Stefan Basel, CH 74 408
VAUPEL, Andrea Basel, CH 48 626
WARIN, Nicolas Basel, CH 6 0
WILCKEN, Rainer Basel, CH 8 1
XUE, Lijun Changshu, Jiangsu, CN 5 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation